Abstract
A controlled study of the effect of aminocaproic acid 3 g six-hourly taken by mouth during menstruation was carried out on 56 women for eight months from the time of insertion of a Lippes D intrauterine device (IUD). Thirty-five women presenting with menorrhagia in association with an IUD were also treated during three out of six consecutive menses. A highly significant reduction in menstrual loss was observed during treatment in both groups.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fulton D. I., Hughes R., Neely M. R. Menorrhagia with intrauterine contraceptive devices. J Obstet Gynaecol Br Commonw. 1967 Oct;74(5):766–767. doi: 10.1111/j.1471-0528.1967.tb03795.x. [DOI] [PubMed] [Google Scholar]
- HALLBERG L., NILSSON L. DETERMINATION OF MENSTRUAL BLOOD LOSS. Scand J Clin Lab Invest. 1964;16:244–248. [PubMed] [Google Scholar]
- Jones R. W., Parker A., Elstein M. Clinical experience with the Dalkon Shield intrauterine device. Br Med J. 1973 Jul 21;3(5872):143–145. doi: 10.1136/bmj.3.5872.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rybo G. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet Gynecol Scand. 1966;45(4):429–450. doi: 10.3109/00016346609158462. [DOI] [PubMed] [Google Scholar]